Collegium Pharmaceutical, Inc. (COLL)
24.29
+0.29
(+1.21%)
USD |
NASDAQ |
Sep 02, 16:00
24.29
0.00 (0.00%)
After-Hours: 17:53
Collegium Pharmaceutical Research and Development Expense (TTM)
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 3.983M |
| September 30, 2022 | 5.592M |
| June 30, 2022 | 7.042M |
| March 31, 2022 | 10.50M |
| December 31, 2021 | 9.451M |
| September 30, 2021 | 10.31M |
| June 30, 2021 | 11.00M |
| March 31, 2021 | 10.04M |
| December 31, 2020 | 9.772M |
| September 30, 2020 | 9.698M |
| June 30, 2020 | 10.05M |
| March 31, 2020 | 10.01M |
| December 31, 2019 | 10.34M |
| Date | Value |
|---|---|
| September 30, 2019 | 10.19M |
| June 30, 2019 | 9.607M |
| March 31, 2019 | 9.385M |
| December 31, 2018 | 8.661M |
| September 30, 2018 | 8.606M |
| June 30, 2018 | 8.768M |
| March 31, 2018 | 8.71M |
| December 31, 2017 | 8.572M |
| September 30, 2017 | 9.709M |
| June 30, 2017 | 10.89M |
| March 31, 2017 | 13.02M |
| December 31, 2016 | 14.95M |
| September 30, 2016 | 13.15M |
| June 30, 2016 | 13.25M |
| March 31, 2016 | 10.59M |
| December 31, 2015 | 7.975M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Innoviva, Inc. | 28.66M |
| Zevra Therapeutics, Inc. | 14.83M |
| Supernus Pharmaceuticals, Inc. | 124.20M |
| Indivior Pharmaceuticals, Inc. | 53.00M |
| Crinetics Pharmaceuticals, Inc. | 371.81M |